Key result
Angiotensin II decreased lipopolysaccharide-stimulated nitric oxide production in rat astroglial cultures by up to approximately 65% through inhibition of iNOS expression.
Angiotensin II decreases LPS-stimulated nitric oxide production in rat astroglia by inhibiting the induction of iNOS expression via the AT1 receptor.
Hypothesis-generating for AT1 effects on glial inflammation; human relevance remains untested.
Consistent with stimulation of expression of an inducible form of nitric oxide synthase (iNOS), exposure of rat astroglial cultures to lipopolysaccharide (LPS) caused a time-dependent increase in the accumulation of nitrite in the culture media. Addition of the peptide angiotensin II (ANG II) with LPS decreased subsequent formation of nitrite in a concentration-dependent manner (concentration inhibiting 50% of maximal response approximately 1 nM). The ANG II effect could be blocked by the ANG II type 1 (AT1 receptor antagonist losartan but not by the ANG II type 2 (AT2) receptor antagonist PD-123177. ANG II had no effect on nitrite formation stimulated by a combination of inflammatory cytokines (interleukin-1 beta, tumor necrosis factor-alpha, and interferon-gamma). A brief 10-min exposure to ANG II was sufficient to cause an approximately 30% inhibition of the LPS response, with maximal inhibition of approximately 65% after 3 h, and occurred only when ANG II was added during the iNOS induction phase. Consistent with partial inhibition of LPS-stimulated expression of iNOS, ANG II reduced the levels of both iNOS mRNA and iNOS protein. These results demonstrate that ANG II can decrease LPS-stimulated NO production in astroglia by inhibiting induction of iNOS expression.
No takes yet. Share an insight, caveat, or question.
Chandler et al. (1995) studied this question. Angiotensin II vs. Lipopolysaccharide alone was evaluated on Nitrite formation and iNOS expression. Angiotensin II decreased lipopolysaccharide-stimulated nitric oxide production in rat astroglial cultures by up to approximately 65% through inhibition of iNOS expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: